{
  "0":{
    "Study":"NRG-GU011",
    "Title":"A Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Prostate",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gu011?filter=nrg-gu011"
  },
  "1":{
    "Study":"NRG-BN011",
    "Title":"A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Brain [BN]",
    "Disease Site":"Malignant Glioma",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-bn011?filter=nrg-bn011"
  },
  "2":{
    "Study":"NRG-HN009",
    "Title":"Randomized Phase II\/III Trial of Radiation with High-Dose Cisplatin (100 mg\/m2) Every Three Weeks versus Radiation with Low-Dose Weekly Cisplatin (40 mg\/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of The Head And Neck (SCCHN)",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Head and Neck [HN]",
    "Disease Site":"Head and Neck",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-hn009?filter=nrg-hn009"
  },
  "3":{
    "Study":"NRG-CC005",
    "Title":"Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Symptom Management [CC]",
    "Disease Site":"Colorectal",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-cc005-forte?filter=nrg-cc005-forte"
  },
  "4":{
    "Study":"NRG-GU010",
    "Title":"Parallel Phase III Randomized Trials Of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification And Intensification Clinical Trial Evaluation (Guidance)",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Prostate",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gu010-1?filter=nrg-gu010-1"
  },
  "5":{
    "Study":"NRG-GY024",
    "Title":"Groningen International Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) III: A Prospective Phase II Treatment Trial",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gy024-1?filter=nrg-gy024-1"
  },
  "6":{
    "Study":"NRG-BN010",
    "Title":"A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Stereotactic Radiotherapy in Recurrent Glioblastoma",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Brain [BN]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-bn010?filter=nrg-bn010"
  },
  "7":{
    "Study":"NRG-BR007",
    "Title":"A Phase III Clinical Trial evaluating De-escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score Less than or Equal to 18: The DEBRA Trial",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Breast [BR]",
    "Disease Site":"Breast",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-br007?filter=nrg-br007"
  },
  "8":{
    "Study":"NRG-GY023",
    "Title":"A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination With Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women With Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Ovarian",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gy023?filter=nrg-gy023"
  },
  "10":{
    "Study":"NRG-CC009",
    "Title":"Phase III Trial of Stereotactic Radiosurgery (SRS) versus Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or Fewer Brain Metastases from Small Cell Lung Cancer",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Symptom Management [CC]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-cc009-1?filter=nrg-cc009-1"
  },
  "14":{
    "Study":"NRG-BN009",
    "Title":"Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for First or Second Distant Brain Relapse After Upfront SRS With Brain Metastasis Velocity \u22654 Brain Metastases\/Year",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Brain [BN]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-bn009?filter=nrg-bn009"
  },
  "15":{
    "Study":"NRG-HN008",
    "Title":"Phase I Trial With Expansion Cohort of DNA-PK Inhibition and IMRT In Cisplatin-Ineligible Patients with Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)",
    "Status":"Open to Accrual",
    "Phase":"I",
    "Disease Category":"Head and Neck [HN]",
    "Disease Site":"Head and Neck",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-hn008?filter=nrg-hn008"
  },
  "16":{
    "Study":"NRG-GU009",
    "Title":"Parallel Phase III Randomized Trials For High Risk Prostate Cancer Evaluating De-Intensification For Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (Predict-RT*) *Prostate RNA Expression\/Decipher To Individualize Concurrent Therapy with Radiation",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Prostate",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gu009-1?filter=nrg-gu009-1"
  },
  "18":{
    "Study":"EA8185",
    "Title":"ECOG-ACRIN\/NRG Joint Study:A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, the INSPIRE Study",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Bladder",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/ea8185?filter=ea8185"
  },
  "19":{
    "Study":"NRG-LU007",
    "Title":"RAndomized Phase II\/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Lung [LU]",
    "Disease Site":"Small Cell",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-lu007?filter=nrg-lu007"
  },
  "21":{
    "Study":"NRG-BN007",
    "Title":"A Randomized Phase II\/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide In Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Brain [BN]",
    "Disease Site":"Malignant Glioma",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-bn007?filter=nrg-bn007"
  },
  "22":{
    "Study":"NRG-CC008",
    "Title":"A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-Oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]",
    "Status":"Open to Accrual",
    "Phase":"Other",
    "Disease Category":"Prevention [CC]",
    "Disease Site":"Ovarian",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-cc008?filter=nrg-cc008"
  },
  "23":{
    "Study":"NRG-HN006",
    "Title":"Randomized Phase II\/III Trial Of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection For Early-Stage Oral Cavity Cancer",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Head and Neck [HN]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-hn006?filter=nrg-hn006"
  },
  "24":{
    "Study":"NRG-GI007",
    "Title":"Phase I Trial with Expansion Cohort of OBP-301 (Telomelysin) and Definitive Chemoradiation for Patients with Locally Advanced Esophageal And Gastroesophageal Adenocarcinoma Who are Not Candidates for Surgery",
    "Status":"Open to Accrual",
    "Phase":"I",
    "Disease Category":"Gastrointestinal [GI]",
    "Disease Site":"Esophageal",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gi007?filter=nrg-gi007"
  },
  "25":{
    "Study":"S1914",
    "Title":"SWOG\/NRG Joint Study: A Randomized Phase III Trial of Induction\/ Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Lung [LU]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/s1914?filter=s1914"
  },
  "26":{
    "Study":"S1806",
    "Title":"SWOG\/NRG Joint Study: Phase III Randomized Trial of Concurrent Chemoradiotherapy with or without Atezolizumab in Localized Muscle Invasive Bladder Cancer",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Bladder",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/s1806?filter=s1806"
  },
  "27":{
    "Study":"NRG-GU008",
    "Title":"Randomized Phase III Trial Incorporating Apalutamide and Advanced Imaging into Salvage Treatment for Patients with Node-Positive Prostate Cancer After Radical Prostatectomy (INNOVATE*) *INtensifying treatment for NOde positive prostate cancer by VArying the hormonal ThErapy",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Prostate",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gu008?filter=nrg-gu008"
  },
  "28":{
    "Study":"NRG-GY020",
    "Title":"A Phase III Randomized Trial of Radiation +\/- Pembrolizumab (MK-3475) for Newly Diagnosed, Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Uterine Corpus",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gy020-1?filter=nrg-gy020-1"
  },
  "29":{
    "Study":"NRG-LU006",
    "Title":"Phase III Randomized Trial of Pleurectomy\/Decortication Plus Chemotherapy With or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) For Malignant Pleural Mesothelioma (MPM)",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Lung [LU]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-lu006?filter=nrg-lu006"
  },
  "30":{
    "Study":"NRG-GI005",
    "Title":"Phase II\/III Study of Circulating tumOr DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Gastrointestinal [GI]",
    "Disease Site":"Colorectal",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gi005-1?filter=nrg-gi005-1"
  },
  "32":{
    "Study":"NRG-GY022",
    "Title":"Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gy022?filter=nrg-gy022"
  },
  "33":{
    "Study":"NRG-GY019",
    "Title":"A Randomized Phase III, Two-Arm Trial of Paclitaxel\/Carboplatin\/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Ovarian",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gy019?filter=nrg-gy019"
  },
  "35":{
    "Study":"NRG-GY018",
    "Title":"A PHASE III RANDOMIZED, PLACEBO-CONTROLLED STUDY OF PEMBROLIZUMAB (MK-3475, NSC #776864) IN ADDITION TO PACLITAXEL AND CARBOPLATIN FOR MEASURABLE STAGE III OR IVA, STAGE IVB OR RECURRENT ENDOMETRIAL CANCER",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Uterine Corpus",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gy018?filter=nrg-gy018"
  },
  "40":{
    "Study":"NRG-GY012",
    "Title":"A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib\/Olaparib, Olaparib\/Durvalumab (MEDI4736), Cediranib\/Durvalumab (MEDI4736), Olaparib\/AZD5363 (Capivasertib) in Women with Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women with Recurrent or Persistent Endometrial Cancer",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Uterine Corpus",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gy012?filter=nrg-gy012"
  },
  "41":{
    "Study":"NRG-GU007",
    "Title":"Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I)",
    "Status":"Open to Accrual",
    "Phase":"I\/II",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Prostate",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gu007?filter=nrg-gu007"
  },
  "43":{
    "Study":"NRG-HN005",
    "Title":"A Randomized Phase II\/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, p16-Positive, Non-Smoking Associated Oropharyngeal Cancer",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Head and Neck [HN]",
    "Disease Site":"Head and Neck",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-hn005?filter=nrg-hn005"
  },
  "46":{
    "Study":"NRG-DT001",
    "Title":"A Phase Ib Trial of Neoadjuvant AMG-232 Concurrent with Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)",
    "Status":"Open to Accrual",
    "Phase":"I",
    "Disease Category":"Other [DT]",
    "Disease Site":"Sarcoma",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-dt001?filter=nrg-dt001"
  },
  "48":{
    "Study":"NRG-LU005",
    "Title":"Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Lung [LU]",
    "Disease Site":"Small Cell",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-lu005?filter=nrg-lu005"
  },
  "53":{
    "Study":"NRG-CC003",
    "Title":"A Randomized Phase II\/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Symptom Management [CC]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-cc003?filter=nrg-cc003"
  },
  "67":{
    "Study":"NRG-CC007CD",
    "Title":"Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Cancer Care Delivery Research [CD]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-cc007cd?filter=nrg-cc007cd"
  },
  "70":{
    "Study":"NRG-BR004",
    "Title":"A Randomized, Double-Blind, Phase III Trial of Taxane\/Trastuzumab\/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Breast [BR]",
    "Disease Site":"Breast",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-br004?filter=nrg-br004"
  },
  "72":{
    "Study":"NRG-GI006",
    "Title":"Phase III Randomized Trial of Proton Beam Therapy (PBT) Versus Intensity Modulated Photon Radiotherapy (IMRT) for the Treatment of Esophageal Cancer",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gastrointestinal [GI]",
    "Disease Site":"Esophageal",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gi006?filter=nrg-gi006"
  },
  "81":{
    "Study":"NRG-GU005",
    "Title":"Phase III IGRT and SBRT versus IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Prostate",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gu005?filter=nrg-gu005"
  },
  "84":{
    "Study":"NRG-HN001",
    "Title":"Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Head and Neck [HN]",
    "Disease Site":"Head and Neck",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-hn001?filter=nrg-hn001"
  },
  "88":{
    "Study":"RTOG-1308",
    "Title":"Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Lung [LU]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/rtog-1308?filter=rtog-1308"
  },
  "89":{
    "Study":"NRG-GI003",
    "Title":"A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gastrointestinal [GI]",
    "Disease Site":"Liver",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gi003?filter=nrg-gi003"
  },
  "90":{
    "Study":"NRG-BN003",
    "Title":"Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Brain [BN]",
    "Disease Site":"Benign Brain Tumors",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-bn003?filter=nrg-bn003"
  },
  "91":{
    "Study":"NRG-BN005",
    "Title":"A Phase II Randomized Trial of Proton vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients with IDH Mutant, Low to Intermediate Grade Gliomas.",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Brain [BN]",
    "Disease Site":"Lower Grade Glioma",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-bn005?filter=nrg-bn005"
  },
  "96":{
    "Study":"AGCT1531",
    "Title":"A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Other",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/agct1531?filter=agct1531"
  },
  "153":{
    "Study":"GOG-0263",
    "Title":"Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I\/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy.",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Cervix",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/gog-0263?filter=gog-0263"
  },
  "155":{
    "Study":"NRG-GI004\/SWOG-S1610",
    "Title":"Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6\/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gastrointestinal [GI]",
    "Disease Site":"Colorectal",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-gi004?filter=nrg-gi004"
  },
  "169":{
    "Study":"NRG-BR003",
    "Title":"A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Breast [BR]",
    "Disease Site":"Breast",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-br003?filter=nrg-br003"
  },
  "175":{
    "Study":"RTOG-0724",
    "Title":"Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Gynecologic [GY]",
    "Disease Site":"Ovarian",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/rtog-0724?filter=rtog-0724"
  },
  "177":{
    "Study":"RTOG-1216",
    "Title":"Randomized Phase II\/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Head and Neck [HN]",
    "Disease Site":"Head and Neck",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/rtog-1216?filter=rtog-1216"
  },
  "192":{
    "Study":"SWOG-S1207 NSABP B-53",
    "Title":"Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +\/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2\/neu Negative Breast Cancer: e3 Breast Cancer Study - Evaluating Everolimus with Endocrine Therapy",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Breast [BR]",
    "Disease Site":"Breast",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/swog-s1207-nsabp-b-53?filter=swog-s1207-nsabp-b-53"
  },
  "193":{
    "Study":"SWOG-S1418 NRG-BR006",
    "Title":"A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with = 1 cm Residual Invasive Cancer or Positive Lymph Nodes (ypN+) after Neoadjuvant Chemotherapy",
    "Status":"Open to Accrual",
    "Phase":"III",
    "Disease Category":"Breast [BR]",
    "Disease Site":"Breast",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/swog-s1418-nrg-br006?filter=swog-s1418-nrg-br006"
  },
  "197":{
    "Study":"NRG-BN001",
    "Title":"Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma",
    "Status":"Open to Accrual",
    "Phase":"II",
    "Disease Category":"Brain [BN]",
    "Disease Site":"Malignant Glioma",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/nrg-bn001?filter=nrg-bn001"
  },
  "199":{
    "Study":"NRG-GU002",
    "Title":"NRG-GU002: Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel",
    "Status":"Open to Accrual",
    "Phase":"II\/III",
    "Disease Category":"Genitourinary [GU]",
    "Disease Site":"Prostate",
    "Enrolled":"",
    "Planned":"",
    "Trial link":"https:\/\/www.nrgoncology.org\/\/Clinical-Trials\/Protocol\/NRG-GU002?filter=NRG-GU002"
  }
}